227results about How to "Reduce food intake" patented technology

A method for the treatment of obesity or other disorders by electrical activation or inhibition of nerves is disclosed. This activation or inhibition can be accomplished by stimulating a nerve using an electrode. Dynamic stimulation through ramped cycling of electrical stimulation, stimulation frequency alteration, and/or duty cycle variance can produce therapeutic benefits.

Methods and devices for simulating a gastric bypass and reducing the volume of the stomach involve placing a tubular liner along the lesser curve of the stomach cavity. Also, methods and devices for slowing gastric emptying involve placing valves within the stomach cavity near the gastrointestinal junction and/or the pylorus. These methods and devices may prevent a patient from drinking and eating large volumes at one time and from eating slowly all day.

The present invention relates to methods and devices that help to curb appetite and/or reduce food intake. In one embodiment, the methods and devices of the present invention include a small intestinal/duodenal insert comprising an elongated member with at least one flow reduction element that can cause the stimulation of one or more biological signals of satiety.

A method for the treatment of obesity or other disorders, by wireless electrical activation or inhibition of the sympathetic nervous system. This activation or inhibition can be accomplished by wirelessly stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using a wireless electrode inductively coupled with a radiofrequency field. The source of radiofrequency energy may be internal or external to the patient. This nerve activation can result in reduced food intake and increased energy expenditure.

Apparatus and methods are described for treatment of morbid obesity using minimally invasive techniques. The apparatus includes a system of components that may be used separately or in combination for effectively reducing stomach volume, bypassing a portion of the stomach and/or small intestines, reducing nutrient absorption in the stomach and/or small intestines and/or depositing minimally or undigested food farther than normal into the intestines, thereby stimulating intestinal responses. The components described include an artificial stoma device, a gastric sleeve device, an intestinal sleeve device and a combined gastrointestinal sleeve device.

A method for the treatment of obesity or other disorders, by electrical activation or inhibition of the sympathetic nervous system. This activation or inhibition can be accomplished by electrically stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an implantable pulse generator. This nerve activation can result in reduced food intake and increased energy expenditure. Reduced food intake may occur through a variety of mechanisms that reduce appetite and cause satiety. Increased adrenal gland hormone levels will result in increased energy expenditure. Fat and carbohydrate metabolism, which are also increased by sympathetic nerve activation, will accompany the increased energy expenditure.

A method for the treatment of obesity or other disorders by electrical activation or inhibition of nerves is disclosed. This activation or inhibition can be accomplished by stimulating a nerve using an electrode. The method further comprises performing a surgical procedure and/or administering a weight loss drug.

A method for treatment of obesity or other disorders by electrical activation or inhibition of nerves is disclosed. This activation or inhibition can be accomplished by stimulating a nerve using an electrode. The method further comprises performing a surgical procedure and/or administering a weight loss drug.

The invention relates to a lLitopenaeus vannamei compound feed and belongs to the field of shrimp feed and preparation methods thereof. According to weight percentage, the compound feed contains 10-15percent of fish meal, 18-22 percent of fermented soybean meal, 8-12 percent of peanut cake, 2-6 percent of corn protein powder, 8-10 percent of soya bean meal, 20-25 percent of high gluten flour, 2-6percent of shrimp shell powder, 1-3 percent of selenium-enriched yeast, 1-3 percent of bentonite, 2-4 percent of squid extract, 2-4 percent of kelp powder, 0.5-1.5 percent of monocalcium phosphate, 0.5-1.5 percent of fish oil and 2-4 percent of premix. The compound feed can substitute for the present prawn compound feed and be used for the artificial breeding of litopenaeus vannamei. The compoundfeed is good in palatability, easy to digest and absorb and nice in the stability in water, reduces feed coefficient and cost, nitrogen and phosphorus emission and pollution to the water body environment of culture zones, and can promote the growth of prawn, with balanced nutrition.

The invention provides a grouper environmentally-friendly soft granulated feed and a preparation method thereof. The grouper environmentally-friendly soft granulated feed comprises the following nutritional components in percentage by weight: 40 to 50 percent of crude protein, 6 to 12 percent of crude fat, 8 to 15 percent of crude ash, 22 to 28 percent of carbohydrate, and 6 to 10 percent of moisture. According to the invention, the high-quality grouper environmentally-friendly soft granulated feed is studied, popularized and applied, so that the nutrition of the launched feed goes to be complete and balanced, and the palatability of the feed is good, not only can the feed digestive absorption rate of grouper be improved, but also the survival rate and growing speed of the grouper are improved, and the fish quality is improved. Therefore, non-polluted fish products are produced, and the cultivation economical benefit is improved; and the feed has active and profound significance in reducing the usage of small trash fish, lightening the sea area pollution, protecting the marine eco-environment, and promoting the sustained stable and health development of the marine fish culture industry.

The invention provides a compound feed capable of improving the fatty liver and body colour of the marine fish. The compound feed comprises a premixed feed, a bile acid, curcumin and betaine, wherein the premixed feed comprises fish meal, soya bean meal, corn gluten meal, high protein flour, corn, shrimp shell meal, monocalcium phosphate, fish oil, liquid phosphatide, vitamin premixes, mineral premixes, and the like. Artificial marine-fish breeding experiments prove that the compound feed provided by the invention can meet the nutritional needs of marine-fish growth, effectively enhance the physique of the marine fish, improve the immunity of the marine fish, reduce the incidence of a fatty liver disease, and improve the body color of the marine fish, so that the body color of the marine fish is bright-colored and close to a wild natural color, thereby enhancing the quality of artificially cultured marine fish.

A method for the treatment of obesity or other disorders by electrical activation or inhibition of the sympathetic nervous system is disclosed. This activation or inhibition can be accomplished by stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an electrode. This nerve activation can result in reduced food intake and increased energy expenditure.

The present invention provides pure nature low temperature baked cooked pumpkin powder and a production method thereof. The production process comprises: carrying out screening, washing, peeling, pulp removing, seed taking and slicing to decompose into pumpkin slices, pumpkin peel, pumpkin pulp and pumpkin seeds; immersing and blanching the pumpkin slices so as to reduce nutrition loss of the pumpkin, immersing and blanching the pumpkin slices with boiling salt water with a temperature of more than or equal to 95 DEG C until achieving a semitransparent state, taking out, dewatering, cutting into strips, carrying out 50-60 DEG C constant temperature vacuum baking processing on the cut pumpkin slice strips, the cut pumpkin peel strips, the cut pumpkin pulp strips and the pumpkin seeds with low temperature baking equipment to obtain cooked and dried pumpkin product, carrying out a mixing stirring sterilization treatment on the cooked and dried pumpkin product, and grinding with a crushing machine to obtain the cooked pumpkin powder with the particle fineness of more than or equal to 120 mesh, wherein the cooked pumpkin powder maintains the nutritional components and the good color of the pumpkin, presents the microscopic porous structure, has good rehydration, can be directly taken through infusion with boiling water, and can further be used as other food preparation materials, and the baked and cooked pumpkin powder, the baked and cooked pumpkin peel powder, the baked and cooked pumpkin pulp powder and the baked and cooked pumpkin seed powder after sterilization can be directly eaten.

The invention relates to meal replacement jelly powder and a preparation method thereof. The meal replacement jelly powder comprises the following components in parts by weight: 20-35% of polydextrose, 1-8% of isomaltulose, 5-15% of konjac glucomannan, 4-10% of carageenan, 0.1-1% of gamma aminobutyric acid and 0.3-1.4% of collagen. According to the meal replacement jelly powder and the preparation method, a jelly form is adopted, so that the product has a good taste and an attractive appearance. Satiety is improved by adding a substance with a meal replacement effect into the meal replacement jelly powder, so that the purpose of slimming is achieved.

The present invention discloses a scientific weight losing fully nutritional powder composition having satiety and belongs to the field of special dietary food processing. The composition is characterized by comprising the following components in percentages by mass: oat dietary fibers, plantago ovate seed shell powder, a garcinia cambogia fruit extract, a green coffee bean extract, sodium caseinate and mogrosides, and is also prepared by mixing the following raw materials: soybean protein isolate, plant fat powder, compound vitamins and compound minerals. By adding the oat dietary fibers, plantago ovate seed shells, sodium caseinate and mogrosides, the composition reaches effects of promoting satiety, moistening intestines and relaxing bowels. By adding the garcinia cambogia fruit extract and coffee bean extract, the composition has effects of inhibiting appetite and promoting fat metabolism. By adding the soybean protein isolate, plant fat powder, compound vitamins and compound minerals, the composition can supplement body with proteins, fats, vitamins and minerals, enables the body to reach purposes of being health and losing weight, and is especially suitable for populations with obesity and overweight.

The invention relates to a feed additive, in particular to a heat-resistant stress feed additive for a cow. The additive comprises the following components in weight portion: 4 to 7 portions of milk veteh, 3 to 6 portions of angelica, 4 to 7 portions of seed cowherb, 2 to 5 portions of licorice, 5 to 8 portions of potassium chloride, 2 to 5 portions of sodium chloride, 1 to 2 portions of magnesium chloride, 2 to 5 portions of sodium bicarbonate, 2 to 5 portions of citric acid and 5 to 10 portions of carrier. The milk veteh, the angelica, the seed cowherb, the licorice, the potassium chloride, the sodium chloride, the magnesium chloride, the sodium bicarbonate and the citric acid are subjected to superfine grinding, filtered by a shaking screen of 100 to 200 meshes, and then mixed with the carrier according to a proportion, stirred evenly, sterilized, cooled, and packaged to prepare the feed additive. The feed additive can improve the heat-resistant stress reaction capability of the cow, enhance immune function of the cow organism, and promote quick rehabilitation of sick livestock, and has the effect of controlling breathing, tonifying the blood, and relaxing vein and promoting milk.

The invention provides a Chinese drug for curing the oesophagus cancer, which comprises a Chinese drug A and a Chinese drug B. The Chinese drug A adopts a hard honeyed pill which is prepared by bornel, cow bezoar, arenobufagin, agalloch, musk, saliter, sal ammoniac, pearl, chlorite schist, asafetida and notoginseng according to a certain proportion by weight, and the Chinese drug B adopts soft honeyed pill which is prepared by Chinese angelica root, root of herbaceous peony, safflower, rhizoma chiuanxiong, burred tuber, zedoary, pinellia, aucklandia root, amomum fruit, corydalis tuber, bitter orange, cuttlebone, barbed stullcap, oldenlandia, arrowhead, aloe, ginseng, atractylodes macrocephala, dried rehmannia root and licorice root according to a certain proportion by weight, and the Chinese drug A and B are separately packed and used together. The Chinese drug for curing the oesophagus cancer has good effects on curing middle-advanced oesophagus cancer, curing hiccought, relieving obstruction and restraining and killing cancer cells.

The invention relates to pudding powder for losing weight and a preparation method of the pudding powder. The pudding powder is prepared by the following components in percentage by weight: 20-50% of polydextrose, 20-50% of crystalline fructose, 3-12% of isomaltulose, 1-6% of konjac glucomannan, 2-6% of carrageenan, 1-5% of xanthan gum, 1-5% of L-carnitine or salt of the L-carnitine, and 1-5% of guarana extract. The pudding powder provided by the invention has a weight-losing effect, and is good in mouthfeel, and easy to be accepted by a great number of consumers.

Pentacyclic triterpene compounds are provided herein. Also provided are pharmaceutical formulations containing a therapeutically effective amount of one or more of the compounds, or pharmaceutically acceptable salts or prodrugs thereof, in combination with one or more pharmaceutically acceptable excipients. The pharmaceutical formulations can be administered to a pre-obese, obese, or morbidly obese patient to induce weight loss, reduce body fat, reduce food intake, improve glucose homeostasis, prevent obesity, or a combination thereof. The compounds can also be co-administered with leptin or a leptin analog.